tech&pharma
A Reality Check On Artificial Intelligence: Are Health Care Claims Overblown?
By Liz Szabo
As happens when the tech industry gets involved, hype surrounds the claims that artificial intelligence will help patients and even replace some doctors.
American Pot Is The Gold Standard. But Canada Leads The Export Game — For Now.
By Markian Hawryluk
American marijuana has a reputation for being the best in the world. But the federal prohibition on marijuana makes shipments across state lines or overseas a pipe dream. While U.S. firms expect the restrictions to drop in the coming years, they are stuck operating within state borders. That’s left Canadian cannabis growers to dominate the export market, with U.S. firms falling further behind each year.
Reports Of Patients’ Deaths Linked To Heart Devices Lurk Below Radar
By Christina Jewett
Because of a little-known federal exemption program, death data about heart devices sits in inaccessible FDA files that can take up to two years for the public to see under open-records laws.
Electronic Health Records Creating A ‘New Era’ Of Health Care Fraud
By Fred Schulte and Erika Fry, Fortune
The federal government funneled billions in subsidies to software vendors and some overstated or deceived the government about what their products could do, according to whistleblowers.
A Veteran Started Vaping THC To Cope With Chronic Pain. Then He Got Very Sick.
By Marlene Harris-Taylor, Ideastream
A Navy veteran from Cleveland tried vaping marijuana to deal with his chronic pain. He landed in the hospital, becoming one of over 2,400 Americans who have suffered serious lung injury from vaping.
Watch: The House Approved H.R. 3, The Pelosi Drug Bill. What Does That Mean?
KHN's Emmarie Huetteman appeared on PBS NewsHour to discuss efforts on Capitol Hill to curb the cost of prescription drugs.
Warren’s Argument That Millions Can’t Afford Their Rx Drugs Holds Up
By Shefali Luthra
‘Medication insecurity’ is a thing.
Effort To Control Opioids In An ER Leaves Some Sickle Cell Patients In Pain
By Sam Whitehead, WABE
People with sickle cell disease aren't fueling the opioid crisis, research shows. Yet some ER doctors still treat patients seeking relief for agonizing sickle cell crises as potential addicts.
HHS Hands Out Free HIV Prevention Drugs. Do You Qualify?
By Carmen Heredia Rodriguez
Called “Ready, Set, PrEP,” the federal program will provide medication that can reduce the chances of getting AIDS to at-risk patients who don’t have insurance.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
By Shefali Luthra
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
Border Fight: Trump’s Plan To Import Cheaper Drugs From Canada Faces Hurdles
By Phil Galewitz
The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.
Listen: The Cost Of PrEP, The HIV Prevention Pill
KHN correspondent Shefali Luthra was among the guests on the podcast "Today, Explained" to talk about PrEP.